Market Notice 82/19 – Information regarding PharmaLundensis AB’s convertible loan
According to a decision by PharmaLundensis AB’s (the Company) board, the Company will issue a convertible loan. The record date is April 11, 2019.
One (1) share (PHAL) entitles the owner to one (1) subscription right. Seventy-one (71) subscription rights entitles the owner to subscribe for one (1) convertible loan at a subscription price of SEK 15,00. The subscription period last from April 15, 2019 to April 30, 2019.
For further information please see todays press release from the company.
Note, the subscription right, the paid subscribed unit and the convertible loan will not be traded at Spotlight Stock Market.
Information about the share:
Short name: PHAL
Market segment: SPSE
MIC Code: XSAT
Stockholm April 4, 2019
Spotlight Stock Market
08-511 68 000